Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Nerve Tissue

Explore clinical trials studying Neoplasms, Nerve Tissue. Study availability and eligibility vary by location and protocol.

6,284 public trials 1,281 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Nerve Tissue trial results

Active, Not Recruiting

ENB003 Plus Pembrolizumab Phase 1b/2a in Solid Tumors

NCT04205227

Conditions
Adnexal Diseases, Cancer, Digestive System Diseases, +30 more
Locations
  • Cedars Sinai-The Angeles Clinic Los Angeles, California, United States
  • MD Anderson Cancer Center Houston, Texas, United States
  • Border Medical Oncology Albury, New South Wales, Australia
  • Blacktown Oncology Blacktown, New South Wales, Australia
View Trial Details
Active, Not Recruiting

A RC198 Study in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors

NCT05867303

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +48 more
Locations
  • ICON Cancer Centre Wesley Auchenflower, Queensland, Australia
  • Southern Oncology Clinical Research Unit Bedford Park, South Australia, Australia
  • Cabrini Hospital Malvern Malvern, Victoria, Australia
  • Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
View Trial Details
Active, Not Recruiting

A Trial of Cabozantinib in Patients With Advanced, Low Proliferative NEN G3

NCT04524208

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Neuroendocrine, +8 more
Locations
  • Medizinische Universität Wien Vienna, Austria
  • University Medical Center Göttingen Göttingen, Lower Saxony, Germany
  • Zentralklinik Bad Berka GmbH Bad Berka, Germany
  • Universitätsklinikum Carl Gustav Carus Dresden, Germany
View all 15 locations
View Trial Details
Active, Not Recruiting

Study of Zirconium Zr 89 Crefmirlimab Berdoxam PET/CT in Subjects With Advanced or Metastatic Malignancies

NCT05013099

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +40 more
Locations
  • CARTI Cancer Center Little Rock, Arkansas, United States
  • City of Hope Duarte, California, United States
  • Providence Saint John's Cancer Institute Santa Monica, California, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View all 16 locations
View Trial Details
Active, Not Recruiting

Adjuvant Nivolumab Treatment in Stage II (IIA, IIB, IIC) High-risk Melanoma

NCT04309409

Conditions
Malignant Melanoma Stage II, Melanoma, Neoplasms, +10 more
Locations
  • Universitätsklinikum Würzburg - Klinik für Dermatologie, Venerologie und Allergologie Würzburg, Bavaria, Germany
  • Universitätsmedizin Rostock -Klinik und Poliklinik für Dermatologie und Venerologie Rostock, Mecklenburg-Vorpommern, Germany
  • Universitätsklinikum Augsburg, Campus Süd Augsburg, Germany
  • St. Josef-Hospital - Dermatologische Studienambulanz Bochum, Germany
View all 20 locations
View Trial Details

Related conditions